Skip to main content

Table 5 General characteristics, cognitive performance, serum B vitamin biomarkers and oxidative biomarkers of study populations for DNA methylation discovery and validation

From: Dietary intakes and biomarker patterns of folate, vitamin B6, and vitamin B12 can be associated with cognitive impairment by hypermethylation of redox-related genes NUDT15 and TXNRD1

 

Human Methylation450K BeadChip for discovery group

MassARRAY EpiTYPER for validation group

MCI

Controls

FDR adjusted P value

MCI

Controls

FDR adjusted P value

N = 7

N = 5

N = 102

N = 68

General characteristics

Age

60.0 ± 2.4

61.4 ± 2.9

0.481

59.6 ± 3.0

59.6 ± 3.4

1.000

Gender (M/F)

3/4

2/3

1

40/62

40/28

0.041*

Education years

9.1 ± 3.3

10.8 ± 1.6

0.474

9 (9, 12)

11 (9, 15)

0.582

BMI (kg/m2)

26.0 ± 2.3

24.1 ± 2.4

0.386

24.2 ± 2.5

25.0 ± 2.7

0.134

Current smoker, n(%)

3 (42.9%)

2 (40.0%)

1

25 (24.5%)

25 (36.8%)

0.226

Current drinker, n(%)

1 (14.3%)

2 (40.0%)

0.572

19 (18.6%)

32 (47.1%)

< 0.001*

Diabetes, n(%)

3 (42.9%)

0 (0.0%)

0.407

20 (19.6%)

8 (11.8%)

0.375

Hypertension, n(%)

3 (42.9%)

2 (40.0%)

1

31 (31.4%)

22 (32.3%)

0.842

CHD, n(%)

2 (28.6%)

0 (0.0%)

0.416

5 (4.9%)

2 (2.9%)

0.691

Cognitive performance

MMSE

28.0 (24.0, 29.0)

28.0 (29.0, 29.0)

0.411

28.0 (27.0, 29.0)

28.5 (27.0, 30.0)

0.226

MoCA

20.3 ± 2.8

26.6 ± 0.9

0.005*

22.4 ± 3.0

26.1 ± 2.3

< 0.001*

AVLT-IR

13.3 ± 4.1

16.8 ± 2.8

0.323

15.3 ± 4.5

18.4 ± 4.7

< 0.001*

AVLT-SR

4.6 ± 3.6

6.4 ± 1.5

0.474

5.1 ± 2.7

6.4 ± 2.3

0.003*

AVLT-LR

3.9 ± 4.0

3.8 ± 2.7

0.96

4 (2, 7)

6 (3, 8)

0.007*

SDMT

30.4 ± 14.3

41.2 ± 8.6

0.336

33 (25, 40)

37 (31, 46)

0.015*

LMT

8.0 ± 3.6

16.2 ± 3.1

0.010*

10.0 (5.5, 13.0)

14.5 (10.0, 16.5)

< 0.001*

DSF

6.5 ± 1.0

8.8 ± 0.8

0.010*

7.2 ± 1.3

7.9 ± 1.5

0.008*

DSB

4.3 ± 1.0

4.8 ± 0.4

0.474

4 (3, 5)

4 (4, 5)

0.016*

Dietary B vitamin intakes

Vitamin B6 (mg/day)

1.9 (1.4, 2.0)

2.6 (1.5, 2.8)

0.596

2.2 (1.8, 2.6)

2.2 (1.7, 2.7)

0.720

Folate (μg/day)

311.6 (203.6, 496.4)

577.2 (239.4, 705.0)

0.596

307.5 (242.6, 442.7)

376.7 (271.8, 532.5)

0.019*

Vitamin B12 (μg/day)

1.2 (0.3, 2.8)

3.2 (1.8, 3.9)

0.427

2.0 (1.3, 2.9)

2.0 (1.2, 3.1)

0.936

Serum B vitamin biomarkers

Vitamin B6 (ng/L)

650.3 ± 125.0

542.3 ± 108.5

0.326

618.6 (531.2, 709.2)

596.5 (514.0, 645.9)

0.193

Folate (μg/L)

15.0 ± 5.6

30.2 ± 3.7

0.003*

17.4 (11.2, 22.8)

32.2 (28.0, 35.6)

< 0.001*

Vitamin B12 (ng/L)

184.0 (113.0, 305.0)

284.0 (216.0, 333.5)

0.573

211.5 (174.8, 262.9)

198.5 (143.5, 256.3)

0.321

Hcy (μmol/L)

22.5 ± 2.9

9.8 ± 2.8

< 0.001*

21.1 (18.3, 23.4)

9.4 (6.7, 11.9)

< 0.001*

Oxidative biomarkers

ROS (IU/ml)

1000.8 ± 345.3

779.1 ± 424.8

0.474

1043.8 (780.2, 1209.5)

728.0 (493.8, 964.8)

< 0.001*

MDA (mmol/L)

10.0 ± 1.7

7.0 ± 3.5

0.225

9.7 ± 2.8

8.1 ± 2.6

0.003*

8-OHdG (ng/L)

338.1 ± 112.2

185.2 ± 46.3

0.061

271.0 (201.1, 341.1)

151.2 (125.9, 176.7)

< 0.001*

8-iso-PGF2α (ng/L)

221.6 ± 59.1

118.2 ± 56.22

0.049*

188.0 (152.0, 279.6)

114.0 (90.3, 144.3)

< 0.001*

  1. MMSE mini-mental state examination, MoCA Montreal Cognitive Assessment, AVLT-IR auditory verbal learning test-immediate recall, AVLT-SR auditory verbal learning test-short recall, AVLT-LR auditory verbal learning test-long recall, SDMT symbol digit modalities test, LMT logical memory test, DSF digit span forwards, DSB digit span backwards, BMI body mass index, CHD coronary heart disease, Hcy homocysteine, ROS reactive oxygen species, MDA malondialdehyde, 8-OHdG 8-hydroxy-desoxyguanosine, 8-iso-PGF2α 8-iso-prostaglandin F2α, FDR false discovery rate
  2. Data shown as median (interquartile range) were compared between two groups using the Mann—Whitney U test
  3. Data shown as mean ± standard deviation were compared between two groups using the Student t test
  4. Data shown as n (%) were compared between two groups using the chi-square test or Fisher’s exact test
  5. ∗P < 0.05